|
Background:
Setting a New
Standard in Bone Strength Assessment:
Omnisense 8000S is the only portable bone assessment device on the market
today with measurement at multiple skeletal sites. Measurement with
Omnisense 8000S is based on Omnipath®, a patented technology
developed for diagnosing and monitoring osteoporosis. With its convenience
in portability, quick-set-up, and compactness, Omnisense 8000S can also be
used as a shared resource or a mobile service.
Point-of-Care
Solution:
Omnisense 8000S is a compact self-contained device based on a familiar
Windows user interface. The Omnisense concept embodies unique patient
history and scheduling features which enable you to easily track
measurement history and monitor treatment.
System
includes:
Omnisense
8000S System includes - CM Probe (Radius), CS Probe (Phalanx),
Soft Shell Transport Case, Spring Gauge Assembly, L-Gauge, Earphone
+ Cable, SOS Verification Phantom, Hand Rest, Skin Marker, Ultrasonic
Gel. HP Deskjet color printer included.
Omnisense
8000S - CR System includes - CR Probe (Metatarsal), CM
Probe (Radius), CS Probe (Phalanx), Soft Shell Transport Case,
Spring Gauge Assembly, L-Gauge, Earphone + Cable, SOS Verification
Phantom, Hand Rest, Skin Marker, Ultrasonic Gel. HP Deskjet color
printer included.
Key Features:
- Measurement at multiple skeletal
sites
- Precise and accurate
- Non-invasive and radiation-free
- Compact and portable
- Cost-effective
- Includes selectable ethnic male
and female reference databases
- Fits WHO criteria for
osteoporosis diagnosis
- FDA and CE approved
Sample
Report:
Multi-Site
Advantage:
Omnisense's
unique probe technology is the only one of its kind. By
enabling multi-site measurements, the Omnisense probe system
provides you with greater diagnostic ability and enhanced
measurement flexibility.
Getting The Whole Picture:
Due to the systemic nature of
osteoporosis, having a multiple site option provides an
overall picture of the skeleton and offers many advantages
to the physician:
 Combining
measurement results of different skeletal sites can
optimize fracture risk assessment.
Using multiple measurement sites enables the physician
to overcome the dilemma of how to
diagnose patients
who:
a. have
a clinical indication of osteoporosis but whose measurement
results do not support this.
b. are
not clearly defined and require a more conclusive
diagnosis.
Monitoring
Response To Treatment:
Different bones respond to treatment at
varying rates and degrees. Using multi-site measurements,
the physician can identify and monitor small bone changes in
a relatively short period of time, allowing more effective
monitoring and treatment decisions.
Omnisense
Forms:
|
